MedTrace Logo

Bausch & Lomb Ophthalmic Viscosurgical Device (OVD) Dispersive (DVisc40)

NCT03511638 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 372

Last updated 2021-10-22

Study results available
· View outcomes & findings →

Summary

A Study to Document the Safety and Effectiveness of a New OVD When Compared to a Control OVD

Conditions

  • Cataract

Interventions

DEVICE

Bausch & Lomb DVisc40

Ophthalmic viscosurgical device

DEVICE

Alcon VISCOAT®

Ophthalmic viscosurgical device

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Anya Loncaric · Bausch Health Americas, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-09
Primary Completion
2019-04-01
Completion
2019-04-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03511638 on ClinicalTrials.gov